Oppenheimer Maintains Outperform on Addus HomeCare, Maintains $118 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has maintained an Outperform rating on Addus HomeCare (NASDAQ:ADUS) and kept the price target at $118.
March 26, 2024 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer reaffirms Outperform rating and $118 price target for Addus HomeCare.
The reaffirmation of an Outperform rating and a high price target by a reputable analyst like Michael Wiederhorn suggests a strong vote of confidence in Addus HomeCare's future performance. This could positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100